Pre-earnings options volume in Sellas Life Sciences (SLS) is 1.5x normal with calls leading puts 430:1. Implied volatility suggests the market is anticipating a move near 22.6%, or 0c, after results are released. Median move over the past eight quarters is 5.5%.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener